Amoxicillin and clavulanic acid in the treatment of actinomycetoma

Int J Dermatol. 1993 Mar;32(3):218-20. doi: 10.1111/j.1365-4362.1993.tb02800.x.

Abstract

Background: Mycetoma is a relatively frequent disease in tropical countries. Drugs commonly used need a long period of treatment, and some cases are resistant to these drugs, especially those with bone or visceral involvement. The combination of amoxicillin-clavulanic acid has shown effectiveness against strains of Nocardia brasiliensis in vitro.

Methods: We have used this combination in two cases of mycetoma caused by N. brasiliensis, both with bone involvement and resistance to the drugs usually used. A dose of three tablets a day for 5 to 6 months was given (each tablet contains 500 mg of amoxicillin and 125 mg of clavulanic acid).

Results: Clinical and mycologic amelioration was observed in the two cases after completing the treatment. There were no side effects or relapses after 3 to 6 months of follow-up after treatment.

Conclusions: We propose this antibiotic as a new option for the treatment of some special cases of actinomycetoma with bone or visceral involvement or resistance to the drugs commonly used in this disease.

Publication types

  • Case Reports

MeSH terms

  • Amoxicillin / administration & dosage*
  • Amoxicillin-Potassium Clavulanate Combination
  • Clavulanic Acids / administration & dosage*
  • Drug Therapy, Combination / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Mycetoma / drug therapy*
  • Mycetoma / pathology
  • Nocardia Infections / drug therapy*
  • Nocardia Infections / pathology

Substances

  • Clavulanic Acids
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin